Barry Labinger - Net Worth and Insider Trading

Barry Labinger Net Worth

The estimated net worth of Barry Labinger is at least $51,371 dollars as of 2024-04-19. Barry Labinger is the EVP, Biosciences Div. of Emergent BioSolutions Inc and owns about 25,182 shares of Emergent BioSolutions Inc (EBS) stock worth over $51,371. Details can be seen in Barry Labinger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Barry Labinger has not made any transactions after 2015-11-13 and currently still holds the listed stock(s).

Transaction Summary of Barry Labinger

To

Barry Labinger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Barry Labinger owns 2 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , and Emergent BioSolutions Inc (EBS) .

Click here to see the complete history of Barry Labinger’s form 4 insider trades.

Insider Ownership Summary of Barry Labinger

Ticker Comapny Transaction Date Type of Owner
CMPI Checkmate Pharmaceuticals Inc 2020-08-06 director & President and CEO
EBS Emergent BioSolutions Inc 2015-11-13 EVP & Biosciences Div.

Barry Labinger Latest Holdings Summary

Barry Labinger currently owns a total of 1 stock. Barry Labinger owns 25,182 shares of Emergent BioSolutions Inc (EBS) as of November 13, 2015, with a value of $51,371.

Latest Holdings of Barry Labinger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EBS Emergent BioSolutions Inc 2015-11-13 25,182 2.04 51,371

Holding Weightings of Barry Labinger


Barry Labinger Form 4 Trading Tracker

According to the SEC Form 4 filings, Barry Labinger has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 3,376 shares on November 13, 2015, which brought Barry Labinger around $123,224.

Insider Trading History of Barry Labinger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Barry Labinger Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Barry Labinger Ownership Network

Ownership Network List of Barry Labinger

No Data

Ownership Network Relation of Barry Labinger


Barry Labinger Owned Company Details

What does Checkmate Pharmaceuticals Inc do?

Who are the key executives at Checkmate Pharmaceuticals Inc?

Barry Labinger is the director & President and CEO of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .

Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Checkmate Pharmaceuticals Inc Insider Transactions

No Available Data

Barry Labinger Mailing Address

Above is the net worth, insider trading, and ownership report for Barry Labinger. You might contact Barry Labinger via mailing address: C/o Checkmate Pharmaceuticals, Inc., 245 Main Street, 2nd Floor, Cambridge Ma 02142.

Discussions on Barry Labinger

No discussions yet.